SignatureFD’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$244K Buy
2,141
+1,009
+89% +$119K ﹤0.01% 1042
2026
Q2
$121K Sell
1,132
-33
-3% -$4K ﹤0.01% 1344
2026
Q1
$190K Buy
1,165
+279
+31% +$42.9K ﹤0.01% 1032
2025
Q4
$154K Buy
886
+272
+44% +$49.6K ﹤0.01% 1105
2025
Q3
$88.4K Buy
614
+79
+15% +$9.7K ﹤0.01% 1355
2025
Q2
$53.8K Sell
535
-332
-38% -$25.4K ﹤0.01% 1543
2025
Q1
$66.1K Buy
867
+325
+60% +$24.9K ﹤0.01% 1421
2024
Q4
$37.4K Buy
542
+99
+22% +$7.13K ﹤0.01% 1730
2024
Q3
$32.3K Buy
443
+104
+31% +$7.68K ﹤0.01% 1820
2024
Q2
$22.7K Buy
339
+49
+17% +$1.9K ﹤0.01% 1897
2024
Q1
$7.87K Sell
290
-14
-5% -$392 ﹤0.01% 2392
2023
Q4
$9.42K Buy
304
+131
+76% +$3.4K ﹤0.01% 2284
2023
Q3
$4.37K Hold
173
– – ﹤0.01% 2539
2023
Q2
$3.65K Buy
173
+138
+394% +$2.62K ﹤0.01% 2619
2023
Q1
$597 Buy
+35
New +$680 ﹤0.01% 3071
2022
Q4
– Sell
-115
Closed -$2K – 3345
2022
Q3
$2K Buy
115
+108
+1,543% +$2.59K ﹤0.01% 2787
2022
Q2
$0 Sell
7
-37
-84% -$775 ﹤0.01% 3226
2022
Q1
$1K Buy
+44
New +$1.02K ﹤0.01% 3002
2020
Q3
– Sell
-43
Closed -$1K – 2670
2020
Q2
$1K Buy
+43
New +$1.02K ﹤0.01% 2319
2020
Q1
– Sell
-138
Closed -$3K – 2374
2019
Q4
$3K Buy
+138
New +$2.81K ﹤0.01% 1790

Other funds holding INSM

SignatureFD's INSM Position: Q3 2026 in Review

SignatureFD increased its Insmed (INSM) stake by 89% in Q3 2026, buying an estimated $119K and bringing the position to 2,141 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

SignatureFD first reported a position in INSM in Q4 2019 and has held it in 20 quarters since. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • SignatureFD held 2,141 shares of Insmed worth $244K as of Q3 2026.
  • SignatureFD bought 1,009 Insmed shares in Q3 2026, an estimated $119K.
  • Insmed made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1042 holding.
  • SignatureFD first reported a position in Insmed in Q4 2019 and has held it in 20 quarters since.
  • 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.